Chondrocalcinosis and haemophilia

Area of Science:

• Rheumatology
• Orthopedics
• Hematology

Background:

• Chondrocalcinosis is observed in various diseases, including hemochromatosis.
• Cartilage calcification has not been previously documented in hemophilia, despite shared joint iron deposition with hemochromatosis.
• Radiographic evidence of chondrocalcinosis is often obscured in advanced hemophilic arthropathy due to severe joint damage.

Purpose of the Study:

• To describe chondrocalcinosis in less severely affected joints of hemophilia patients.
• To review the role of pyrophosphatase inhibition by divalent cations in calcium pyrophosphate dihydrate (CPPD) deposition.
• To discuss the biomechanics of articular cartilage and the impact of divalent cations.

Main Methods:

• Case series describing three patients with Factor VII, AHG-deficient hemophilia.
• Review of literature on chondrocalcinosis, hemophilia, and divalent cation effects on cartilage.
• Discussion of potential pathomechanisms linking joint changes and calcification.

Main Results:

• Chondrocalcinosis was observed in the less damaged joints of three hemophilia patients.
• Pyrophosphatase inhibition by divalent cations is a known mechanism for CPPD deposition.
• Divalent cations affect normal cartilage elasticity and may contribute to degenerative changes.

Conclusions:

• This study reports chondrocalcinosis in hemophilia, a novel finding.
• Abnormal divalent cations are suggested as a potential simultaneous cause for degenerative joint disease and chondrocalcinosis in hemophilia.
• Further research is warranted to elucidate the precise role of divalent cations in hemophilic arthropathy and chondrocalcinosis.